Related Experiment Video
Updated: May 19, 2026

Methods for the Modulation and Analysis of NF-κB-dependent Adult Neurogenesis
Published on: February 13, 2014
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice
Cristina Baiguera1, Manuela Alghisi, Annalisa Pinna
1Department of Biomedical Sciences and Biotechnologies, University of Brescia and National Institute of Neuroscience, 25123 Brescia, Italy.
Abstract:
Activation of the nuclear factor κB/c-Rel can increase neuronal resilience to pathological noxae by regulating the expression of pro-survival manganese superoxide dismutase (MnSOD, now known as SOD2) and Bcl-xL genes. We show here that c-Rel-deficient (c-rel(-/-)) mice developed a Parkinson's disease-like neuropathology with ageing. At 18 months of age, c-rel(-/-) mice exhibited a significant loss of dopaminergic neurons in the substantia nigra pars compacta, as assessed by tyrosine hydroxylase-immunoreactivity and Nissl staining. Nigral degeneration was accompanied by a significant loss of dopaminergic terminals and a significant reduction of dopamine and homovanillic acid levels in the striatum. Mice deficient of the c-Rel factor exhibited a marked immunoreactivity for fibrillary α-synuclein in the substantia nigra pars compacta as well as increased expression of divalent metal transporter 1 (DMT1) and iron staining in both the substantia nigra pars compacta and striatum. Aged c-rel(-/-) mouse brain were characterized by increased microglial reactivity in the basal ganglia, but no astrocytic reaction. In addition, c-rel(-/-) mice showed age-dependent deficits in locomotor and total activity and various gait-related deficits during a catwalk analysis that were reminiscent of bradykinesia and muscle rigidity. Both locomotor and gait-related deficits recovered in c-rel(-/-) mice treated with l-3,4-dihydroxyphenylalanine. These data suggest that c-Rel may act as a regulator of the substantia nigra pars compacta resilience to ageing and that aged c-rel(-/-) mice may be a suitable model of Parkinson's disease.
Insights
Mice lacking the nuclear factor c-Rel develop Parkinson's disease-like symptoms with age, including neuron loss and motor deficits. These findings highlight c-Rel's role in protecting brain cells and suggest a new Parkinson's disease model.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Nuclear factor κB/c-Rel activation enhances neuronal resilience by regulating pro-survival genes.
- Dysregulation of neuroprotective pathways is implicated in neurodegenerative diseases.
Purpose of the Study:
- To investigate the role of c-Rel in neuronal resilience and its potential involvement in Parkinson's disease pathogenesis.
- To characterize the neuropathology and behavioral deficits in c-Rel-deficient mice.
Main Methods:
- Utilized c-Rel-deficient (c-rel(-/-)) mice aged to 18 months.
- Assessed dopaminergic neuron loss via tyrosine hydroxylase-immunoreactivity and Nissl staining.
- Quantified striatal dopamine and homovanillic acid levels.
- Examined α-synuclein, DMT1, and iron expression.
- Evaluated microglial and astrocytic reactivity.
- Performed locomotor and gait analyses, followed by l-3,4-dihydroxyphenylalanine treatment.
Main Results:
- Aged c-rel(-/-) mice exhibited significant loss of dopaminergic neurons in the substantia nigra pars compacta.
- Nigral degeneration correlated with reduced striatal dopamine levels and dopaminergic terminals.
- Increased α-synuclein, DMT1, and iron staining were observed in c-rel(-/-) mice.
- These mice displayed age-dependent motor deficits, including bradykinesia and rigidity, which improved with L-DOPA treatment.
Conclusions:
- c-Rel deficiency leads to Parkinson's disease-like neuropathology and motor impairments in aging mice.
- c-Rel appears to be a critical regulator of substantia nigra pars compacta resilience.
- Aged c-rel(-/-) mice represent a valuable model for studying Parkinson's disease.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Neural Regulation
